SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14C - Preliminary information statements relating to merger or acquisition:
SEC Accession No. 0001493152-20-016321
Filing Date
2020-08-19
Accepted
2020-08-19 16:41:30
Documents
4
Period of Report
2020-08-19

Document Format Files

Seq Description Document Type Size
1 prem14c.htm PREM14C 3845254
2 report_001.jpg GRAPHIC 26725
3 exb_001.jpg GRAPHIC 223346
4 exb_002.jpg GRAPHIC 208313
  Complete submission text file 0001493152-20-016321.txt   4478133
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PREM14C | Act: 34 | File No.: 000-52218 | Film No.: 201117503
SIC: 2834 Pharmaceutical Preparations